JPMorgan Investors Show Support for Dimon in Cancer Fight
JPMorgan Chase CEO Jamie Dimon will start treatment for throat cancer, raising new questions about succession plans at the biggest U.S. bank.
VP in Conflicts Office at J.P. Morgan Securities Barred for Leaking Inside Info
“Gutman had the keys to the kingdom through his position at J.P. Morgan as a gatekeeper with special access to material, nonpublic information,” FINRA says.
Citigroup, Smith Barney Emerge Unscathed From Mutual Fund Suit
Citigroup and its former Smith Barney brokerage unit, together with two executives, saw nearly all claims thrown out in a lawsuit that accused them of shortchanging mutual fund investors out of more than $100 million in fee discounts.
COR Securities Buys Clearing Firm Legent
COR Securities Holdings announced Tuesday that it has acquired independent securities clearing firm Legent Clearing.
John C. Thompson of Thompson Plumb Growth Fund
S&P Rank: 5 Stars Growth, By Any Other Name